BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9793769)

  • 1. Expression of p53 protein in pterygium.
    Onur C; Orhan D; Orhan M; Dizbay Sak S; Tulunay O; IrkeƧ M
    Eur J Ophthalmol; 1998; 8(3):157-61. PubMed ID: 9793769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress in pterygium: relationship between p53 and 8-hydroxydeoxyguanosine.
    Perra MT; Maxia C; Corbu A; Minerba L; Demurtas P; Colombari R; Murtas D; Bravo S; Piras F; Sirigu P
    Mol Vis; 2006 Sep; 12():1136-42. PubMed ID: 17093398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors.
    Dushku N; Reid TW
    Curr Eye Res; 1997 Dec; 16(12):1179-92. PubMed ID: 9426949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of survivin protein in pterygium and relationship with oxidative DNA damage.
    Maxia C; Perra MT; Demurtas P; Minerba L; Murtas D; Piras F; Corbu A; Gotuzzo DC; Cabrera RG; Ribatti D; Sirigu P
    J Cell Mol Med; 2008 Dec; 12(6A):2372-80. PubMed ID: 18266976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 Expression in pterygium by immunohistochemical analysis: a series report of 127 cases and review of the literature.
    Tsai YY; Chang KC; Lin CL; Lee H; Tsai FJ; Cheng YW; Tseng SH
    Cornea; 2005 Jul; 24(5):583-6. PubMed ID: 15968165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 gene mutation spectrum and the relationship between gene mutation and protein levels in pterygium.
    Tsai YY; Cheng YW; Lee H; Tsai FJ; Tseng SH; Chang KC
    Mol Vis; 2005 Jan; 11():50-5. PubMed ID: 15682042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV infection and p53 inactivation in pterygium.
    Tsai YY; Chang CC; Chiang CC; Yeh KT; Chen PL; Chang CH; Chou MC; Lee H; Cheng YW
    Mol Vis; 2009 Jun; 15():1092-7. PubMed ID: 19503739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA damage in human pterygium: one-shot multiple targets.
    Cimpean AM; Sava MP; Raica M
    Mol Vis; 2013; 19():348-56. PubMed ID: 23401662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity and p53 expression in Pterygium.
    Reisman D; McFadden JW; Lu G
    Cancer Lett; 2004 Mar; 206(1):77-83. PubMed ID: 15019163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 expression in pterygium in two climatic regions in Turkey.
    Pelit A; Bal N; Akova YA; Demirhan B
    Indian J Ophthalmol; 2009; 57(3):203-6. PubMed ID: 19384014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CREB in primary pterygium and correlation with cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin.
    Nubile M; Curcio C; Lanzini M; Calienno R; Iezzi M; Mastropasqua A; Di Nicola M; Mastropasqua L
    Ophthalmic Res; 2013; 50(2):99-107. PubMed ID: 23838680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity and p53 expression in pterygia.
    Shimmura S; Ishioka M; Hanada K; Shimazaki J; Tsubota K
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1364-9. PubMed ID: 10798651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between BPDE-like DNA adduct levels and P53 gene mutation in pterygium.
    Lai TJ; Tsai YY; Cheng YW; Chiang CC; Lee H; Chou MC; Chang JH
    Mol Vis; 2006 Dec; 12():1687-91. PubMed ID: 17213797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical study of p53, p21 and PCNA in pterygium.
    Ueda Y; Kanazawa S; Kitaoka T; Dake Y; Ohira A; Ouertani AM; Amemiya T
    Acta Histochem; 2001 Apr; 103(2):159-65. PubMed ID: 11368097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of p53 codon 72 polymorphism on p53 protein expression in pterygium.
    Tsai YY; Chang KC; Lee H; Cheng YW; Tsai FJ; Tseng SH; Ao HS; Chau PS
    Clin Exp Ophthalmol; 2005 Feb; 33(1):60-2. PubMed ID: 15670080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of p53 tumor suppressor gene in pterygia.
    Weinstein O; Rosenthal G; Zirkin H; Monos T; Lifshitz T; Argov S
    Eye (Lond); 2002 Sep; 16(5):619-21. PubMed ID: 12194078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical analysis of vascular endothelial growth factor (VEGF) and p53 expression in pterygium from Tunisian patients.
    Khalfaoui T; Mkannez G; Colin D; Imen A; Zbiba W; Errais K; Anane R; Beltaief O; Zhioua R; Ben Hamida J; Lizard G; Ouertani-Meddeb A
    Pathol Biol (Paris); 2011 Jun; 59(3):137-41. PubMed ID: 19481369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjunctival Expression of Toll-Like Receptor 3 Plays a Pathogenic Role in the Formation of Ultraviolet Light-Induced Pterygium.
    Lai CC; Tseng SH; Hsu SM; Huang YT; Shieh CC
    Invest Ophthalmol Vis Sci; 2021 Aug; 62(10):6. PubMed ID: 34369985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2, p53, and Ki-67 expression in pterygium and normal conjunctiva and their relationship with pterygium recurrence.
    Turan M; Turan G
    Eur J Ophthalmol; 2020 Nov; 30(6):1232-1237. PubMed ID: 32703006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of p53 in pterygium influence miR-200a expression resulting in ZEB1/ZEB2 up-regulation and EMT processing.
    Wu CW; Peng ML; Yeh KT; Tsai YY; Chiang CC; Cheng YW
    Exp Eye Res; 2016 May; 146():206-211. PubMed ID: 26995143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.